Annexon (ANNX) Provides 2025 Outlook with Strong Momentum Accelerating into Breakthrough Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St set to snap three-day losing streak as stocks reclaim some shine
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Annexon Provides 2025 Outlook with Strong Momentum Accelerating into Breakthrough Year
January 13, 2025 8:00 AM ESTANX005 First Potential Targeted Therapy for Guillain-Barré Syndrome Advancing Towards 1H 2025 BLA Submission
ANX007 First Potential Neuroprotective Therapy for Geographic Atrophy Expected to Complete Enrollment of Phase 3 ARCHER II Trial in 2H 2025
ANX1502 First Oral C1s Inhibitor On Track for Clinical Proof of Concept Data in 1Q 2025
Cash Runway into 2H 2026 to Achieve Key Milestones
BRISBANE, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) --... More
